3576 related articles for article (PubMed ID: 19590231)
1. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
2. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
MacLaughlin HL; Cook SA; Kariyawasam D; Roseke M; van Niekerk M; Macdougall IC
Am J Kidney Dis; 2010 Jan; 55(1):69-76. PubMed ID: 19926371
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and the risk of progression of chronic kidney disease.
Khedr A; Khedr E; House AA
J Ren Nutr; 2011 Nov; 21(6):455-61. PubMed ID: 21454093
[TBL] [Abstract][Full Text] [Related]
4. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
5. An association between body mass index and estimated glomerular filtration rate.
Kawamoto R; Kohara K; Tabara Y; Miki T; Ohtsuka N; Kusunoki T; Yorimitsu N
Hypertens Res; 2008 Aug; 31(8):1559-64. PubMed ID: 18971530
[TBL] [Abstract][Full Text] [Related]
6. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
7. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
10. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.
Lo JC; Go AS; Chandra M; Fan D; Kaysen GA
Am J Kidney Dis; 2007 Oct; 50(4):552-8. PubMed ID: 17900454
[TBL] [Abstract][Full Text] [Related]
11. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
[TBL] [Abstract][Full Text] [Related]
12. Bariatric surgery and progression of chronic kidney disease.
Navaneethan SD; Yehnert H
Surg Obes Relat Dis; 2009; 5(6):662-5. PubMed ID: 19359221
[TBL] [Abstract][Full Text] [Related]
13. Association of body mass index with decline in residual kidney function after initiation of dialysis.
Drechsler C; de Mutsert R; Grootendorst DC; Boeschoten EW; Krediet RT; le Cessie S; Wanner C; Dekker FW;
Am J Kidney Dis; 2009 Jun; 53(6):1014-23. PubMed ID: 19217702
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic kidney disease in the Black Sea Region, Turkey, and investigation of the related factors with chronic kidney disease.
Sahin I; Yildirim B; Cetin I; Etikan I; Ozturk B; Ozyurt H; Tasliyurt T
Ren Fail; 2009; 31(10):920-7. PubMed ID: 20030527
[TBL] [Abstract][Full Text] [Related]
15. Pulse pressure and progression of chronic kidney disease.
Arulkumaran N; Diwakar R; Tahir Z; Mohamed M; Kaski JC; Banerjee D
J Nephrol; 2010; 23(2):189-93. PubMed ID: 20119928
[TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
17. The obesity paradox, weight loss, and coronary disease.
Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
[TBL] [Abstract][Full Text] [Related]
19. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
[TBL] [Abstract][Full Text] [Related]
20. Obesity-related glomerulopathy in China: a case series of 90 patients.
Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
